Johnson & Johnson (JNJ) operating KPIs
JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)
Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%
Johnson & Johnson cash dividends paid per share ($) ($)
Form 10-Q / 10-K Consolidated Statements of Operations & Equity
Latest, Q3 2026
1.34
Period ended Sep 30, 2026
Change on a year earlier
+3.1%
1.30 in Q3 2025
History
33 quarters
Since Q1 2016
Sources
25
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cash dividends paid per share ($) ($) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | 1.34 | +3.1% | Form 10-Q (filed 2026-10-21) ↗ |
| Q2 2026 | Jun 28, 2026 | 1.34 | +3.1% | Form 10-Q (filed 2026-07-23) ↗ |
| Q1 2026 | Mar 29, 2026 | 1.30 | +4.8% | Form 10-Q (filed 2026-04-22) ↗ |
| Q3 2025 | Sep 28, 2025 | 1.30 | +4.8% | Form 10-Q (filed 2026-10-21) ↗ |
| Q2 2025 | Jun 29, 2025 | 1.30 | +4.8% | Form 10-Q (filed 2026-07-23) ↗ |
| Q1 2025 | Mar 30, 2025 | 1.24 | +4.2% | Form 10-Q (filed 2026-04-22) ↗ |
| Q3 2024 | Sep 29, 2024 | 1.24 | +4.2% | Form 10-Q (filed 2025-10-22) ↗ |
| Q2 2024 | Jun 30, 2024 | 1.24 | +4.2% | Form 10-Q (filed 2025-07-24) ↗ |
| Q1 2024 | Mar 31, 2024 | 1.19 | +5.3% | Form 10-Q (filed 2025-04-23) ↗ |
| Q3 2023 | Oct 1, 2023 | 1.19 | +5.3% | Form 10-Q (filed 2024-10-23) ↗ |
| Q2 2023 | Jul 2, 2023 | 1.19 | +5.3% | Form 10-Q (filed 2024-07-25) ↗ |
| Q1 2023 | Apr 2, 2023 | 1.13 | +6.6% | Form 10-Q (filed 2024-05-01) ↗ |
| Q3 2022 | Oct 2, 2022 | 1.13 | +6.6% | Form 10-Q (filed 2023-10-27) ↗ |
| Q2 2022 | Jul 3, 2022 | 1.13 | +6.6% | Form 10-Q (filed 2023-07-31) ↗ |
| Q1 2022 | Apr 3, 2022 | 1.06 | +5.0% | Form 10-Q (filed 2023-04-28) ↗ |
| Q3 2021 | Oct 3, 2021 | 1.06 | +5.0% | Form 10-Q (filed 2022-10-27) ↗ |
| Q2 2021 | Jul 4, 2021 | 1.06 | +5.0% | Form 10-Q (filed 2022-07-29) ↗ |
| Q1 2021 | Apr 4, 2021 | 1.01 | +6.3% | Form 10-Q (filed 2022-04-29) ↗ |
| Q3 2020 | Sep 27, 2020 | 1.01 | +6.3% | Form 10-Q (filed 2021-10-29) ↗ |
| Q2 2020 | Jun 28, 2020 | 1.01 | +6.3% | Form 10-Q (filed 2021-07-29) ↗ |
| Q1 2020 | Mar 29, 2020 | 0.95 | +5.6% | Form 10-Q (filed 2021-04-30) ↗ |
| Q3 2019 | Sep 29, 2019 | 0.95 | +5.6% | Form 10-Q (filed 2020-10-23) ↗ |
| Q2 2019 | Jun 30, 2019 | 0.95 | +5.6% | Form 10-Q (filed 2020-07-24) ↗ |
| Q1 2019 | Mar 31, 2019 | 0.90 | +7.1% | Form 10-Q (filed 2019-05-01) ↗ |
| Q3 2018 | Sep 30, 2018 | 0.90 | +7.1% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2018 | Jul 1, 2018 | 0.90 | +7.1% | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2018 | Apr 1, 2018 | 0.84 | +5.0% | Form 10-Q (filed 2019-05-01) ↗ |
| Q3 2017 | Oct 1, 2017 | 0.84 | +5.0% | Form 10-Q (filed 2018-10-31) ↗ |
| Q2 2017 | Jul 2, 2017 | 0.84 | +5.0% | Form 10-Q (filed 2018-08-02) ↗ |
| Q1 2017 | Apr 2, 2017 | 0.80 | +6.7% | Form 10-Q (filed 2018-05-01) ↗ |
| Q3 2016 | Oct 2, 2016 | 0.80 | – | 10-Q FY2016 (XBRL) ↗ |
| Q2 2016 | Jul 3, 2016 | 0.80 | – | 10-Q FY2016 (XBRL) ↗ |
| Q1 2016 | Apr 3, 2016 | 0.75 | – | 10-Q FY2016 (XBRL) ↗ |
Cite this data
StockData. (2026). Johnson & Johnson Cash dividends paid per share ($) ($), quarterly Q1 2016–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/div_paid_ps
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.